Dr. Teo Soleymani discusses new cutting-edge treatment option for early melanoma
May is skin cancer awareness month and skin cancer is the most common cancer of all. Melanoma is the deadliest form of skin cancer. It is reported every 52 minutes someone dies from melanoma. UCLA is offering a new cutting edge treatment option for early melanoma, one that provides a cure rate that’s 20-100x better than standard therapies.
Dr. Teo Soleymani, board-certified dermatologist and fellowship-trained Mohs Micrographic and Reconstructive Surgeon, specialist in the management and treatment of complex and high-risk skin cancer, joined Good Day LA on May 14 to discuss this new treatment.